Avg closing price
Price range

8 Cathie Wood Vertex Pharmaceuticals Trades

Cathie Wood's position in Vertex Pharmaceuticals is currently worth $107 Million. That's 0.58% of their equity portfolio (32nd largest holding). Cathie Wood started to build up the position in Vertex Pharmaceuticals in Q3 2020 and continued to invest until Q2 2021. Since then they sold 1.41 Million shares. The stake costed the investor $82.7 Million, netting the investor a gain of 30% so far.

Avg closing price
Price range
Sold 13.3% shares (-56.3 Thousand shares) Q2 2022
Avg closing price $267.66
Price range $234.96 - $292.55
Sold 54.6% shares (-507 Thousand shares) Q1 2022
Avg closing price $237.33
Price range $221.42 - $260.97
Sold 45.7% shares (-781 Thousand shares) Q4 2021
Avg closing price $194.45
Price range $177.01 - $223.45
Sold 3.6% shares (-64.3 Thousand shares) Q3 2021
Avg closing price $195.24
Price range $181.39 - $202.99
Increased shares by 3.2% (+55 Thousand shares) Q2 2021
Avg closing price $209.17
Price range $187.49 - $221.10
Increased shares by 110.6% (+903 Thousand shares) Q1 2021
Avg closing price $219.65
Price range $207.02 - $241.31
Increased shares by 738.4% (+719 Thousand shares) Q4 2020
Avg closing price $229.44
Price range $207.01 - $276.09
New holding (+97.4 Thousand shares) Q3 2020
Avg closing price $275.88
Price range $255.65 - $303.10

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!